Cargando…
Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening
Oral cancer is one of the most common cancers globally. Survival rates for patients are directly correlated with stage of diagnosis; despite this knowledge, 60% of individuals are presenting with late-stage disease. Currently, the initial evaluation of a questionable lesion is performed by a convent...
Autores principales: | Strome, Arianna, Kossatz, Susanne, Zanoni, Daniella Karassawa, Rajadhyaksha, Milind, Patel, Snehal, Reiner, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287312/ https://www.ncbi.nlm.nih.gov/pubmed/32852263 http://dx.doi.org/10.1177/1536012118808644 |
Ejemplares similares
-
Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers
por: Kossatz, Susanne, et al.
Publicado: (2020) -
Detection and Delineation of Oral Cancer With a PARP1-Targeted Optical Imaging Agent
por: Kossatz, Susanne, et al.
Publicado: (2017) -
Fluorescence-guided resection of tumors in mouse models of oral cancer
por: Demétrio de Souza França, Paula, et al.
Publicado: (2020) -
Optical Imaging of PARP1 in Response to Radiation in Oral Squamous Cell Carcinoma
por: Kossatz, Susanne, et al.
Publicado: (2016) -
Acid specific dark quencher QC1 pHLIP for multi-spectral optoacoustic diagnoses of breast cancer
por: Roberts, Sheryl, et al.
Publicado: (2019)